Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-10-23

Clinical Trial Update: Bryophyllum vs. Nifedipine [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 trial compares Bryophyllum with Nifedipine for tocolysis in preterm labor; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bryophyllum (Bryophyllum pinnatum)
  • Nifedipine (nifedipine)

Snippet

Sponsor: Weleda AG | Conditions: Tocolysis | Phase 2, Phase 3 | Status: UNKNOWN